Clinical Trial Update: Evaluating a Fasting-mimicking Diet in Combination With Immunotherapy in Patients With Non-small Cell Lung Cancer [NA]

View source ↗

Summary

A clinical trial is evaluating a fasting-mimicking diet in combination with immunotherapy for stage IV non-small cell lung cancer and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: VA Office of Research and Development | Conditions: Stage IV NSCLC, NSCLC | NA | Status: RECRUITING